The synergistic regulatory effect of Runx2 and MEF transcription factors on osteoblast differentiation markers
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Purpose: Bone tissues for clinical application can be improved by studies on osteoblast differentiation. Runx2 is known to be an important transcription factor for osteoblast differentiation. However, bone morphogenetic protein (BMP)-2 treatment to stimulate Runx2 is not sufficient to acquire enough bone formation in osteoblasts. Therefore, it is necessary to find other regulatory factors which can improve the transcriptional activity of Runx2. The erythroblast transformation-specific (ETS) transcription factor family is reported to be involved in various aspects of cellular proliferation and differentiation. Methods: We have noticed that the promoters of osteoblast differentiation markers such as alkaline phosphatase (Alp), osteopontin (Opn), and osteocalcin (Oc) contain Ets binding sequences which are also close to Runx2 binding elements. Luciferase assays were performed to measure the promoter activities of these osteoblast differentiation markers after the transfection of Runx2, myeloid Elf-1-like factor (MEF), and Runxs+MEF. Reverse-transcription polymerase chain reaction was also done to check the mRNA levels of Opn after Runx2 and MEF transfection into rat osteoblast (ROS) cells. Results: We have found that MEF, an Ets transcription factor, increased the transcriptional activities of Alp, Opn, and Oc. The addition of Runx2 resulted in the 2- to 6-fold increase of the activities. This means that these two ranscription factors have a synergistic effect on the osteoblast differentiation markers. Furthermore, early introduction of these two Runx2 and MEF factors significantly elevated the expression of the Opn mRNA levels in ROS cells. We also showed that Runx2 and MEF proteins physically interact with each other. Conclusions: Runx2 interacts with MEF proteins and binds to the promoters of the osteoblast markers such as Opn nearby MEF to increase its transcriptional activity. Our results also imply that osteoblast differentiation and bone formation can be increased by activating MEF to elicit the synergistic effect of Runx2 and MEF.
Abstract
Purpose: Bone tissues for clinical application can be improved by studies on osteoblast differentiation. Runx2 is known to be an important transcription factor for osteoblast differentiation. However, bone morphogenetic protein (BMP)-2 treatment to stimulate Runx2 is not sufficient to acquire enough bone formation in osteoblasts. Therefore, it is necessary to find other regulatory factors which can improve the transcriptional activity of Runx2. The erythroblast transformation-specific (ETS) transcription factor family is reported to be involved in various aspects of cellular proliferation and differentiation. Methods: We have noticed that the promoters of osteoblast differentiation markers such as alkaline phosphatase (Alp), osteopontin (Opn), and osteocalcin (Oc) contain Ets binding sequences which are also close to Runx2 binding elements. Luciferase assays were performed to measure the promoter activities of these osteoblast differentiation markers after the transfection of Runx2, myeloid Elf-1-like factor (MEF), and Runxs+MEF. Reverse-transcription polymerase chain reaction was also done to check the mRNA levels of Opn after Runx2 and MEF transfection into rat osteoblast (ROS) cells. Results: We have found that MEF, an Ets transcription factor, increased the transcriptional activities of Alp, Opn, and Oc. The addition of Runx2 resulted in the 2- to 6-fold increase of the activities. This means that these two ranscription factors have a synergistic effect on the osteoblast differentiation markers. Furthermore, early introduction of these two Runx2 and MEF factors significantly elevated the expression of the Opn mRNA levels in ROS cells. We also showed that Runx2 and MEF proteins physically interact with each other. Conclusions: Runx2 interacts with MEF proteins and binds to the promoters of the osteoblast markers such as Opn nearby MEF to increase its transcriptional activity. Our results also imply that osteoblast differentiation and bone formation can be increased by activating MEF to elicit the synergistic effect of Runx2 and MEF.
참고문헌 (25)
- Boyle WJ, "Osteoclast differentiation and activation", Nature, 423, pp.337~342 (2003)
- Blair HC, "Mechanisms balancing skeletal matrix synthesis and degradation", Biochem J, 364, pp.329~341 (2002)
- Teitelbaum SL, "Osteoclasts, integrins, and osteoporosis", J Bone Mineral Metab, 18, pp.344~349 (2000)
- Karsenty G, "Reaching a genetic and molecular understanding of skeletal development", Dev Cell, 2, pp.389~406 (2002)
- Lemaire V, "Modeling the interactions between osteoblast and osteoclast activities in bone remodeling", J Theor Biol, 229, pp.293~309 (2004)
- Teitelbaum SL, "Bone resorption by osteoclasts", Science, 289, pp.1504~1508 (2000)
- Ducy P, "The osteoblast: a sophisticated fibroblast under central surveillance", Science, 289, pp.1501~1504 (2000)
- Harada S, "Control of osteoblast function and regulation of bone mass", Nature, 423, pp.349~355 (2003)
- Olsen BR, "Bone development", Ann Rev Cell Dev Biol, 16, pp.191~220 (2000)
- Katagiri T, "Regulatory mechanisms of osteoblast and osteoclast differentiation", Oral Dis, 8, pp.147~159 (2002)
- Wagner EF, "Genetic control of skeletal development", Curr Opin Genet Dev, 11, pp.527~532 (2001)
- Deng ZL, "Regulation of osteogenic differentiation during skeletal development", Front Biosci, 13, pp.2001~2021 (2008)
- Raouf A, "Ets transcription factors and targets in osteogenesis", Oncogene, 19, pp.6455~6463 (2000)
- Miyazaki Y, "MEF, a novel transcription factor with an Elf-1 like DNA binding domain but distinct transcriptional activating properties", Oncogene, 13, pp.1721~1729 (1996)
- Suico MA, "Functional dissection of the ETS transcription factor MEF", Biochim Biophys Acta, 1577, pp.113~120 (2002)
- Hedvat CV, "Myeloid ELF1-like factor is a potent activator of interleukin-8 expression in hematopoietic cells", J Biol Chem, 279, pp.6395~6400 (2004)
- Lu Z, "MEF upregulates human beta-defensin 2 expression in epithelial cells", FEBS Lett, 561, pp.117~121 (2004)
- Lee MH, "BMP-2-induced Runx2 expression is mediated by Dlx5, and TGF-beta 1 opposes the BMP-2-induced osteoblast differentiation by suppression of Dlx5 expression", J Biol Chem, 278, pp.34387~34394 (2003)
- Harada H, "Cbfa1 isoforms exert functional differences in osteoblast differentiation", J Biol Chem, 274, pp.6972~6978 (1999)
- Towler DA, "Activity of the rat osteocalcin basal promoter in osteoblastic cells is dependent upon homeodomain and CP1 binding motifs", Mol Endocrinol, 8, pp.614~624 (1994)
- Towler DA, "Msx-2", Hox 8.1: a transcriptional regulator of the rat osteocalcin promoter, 1994, pp.8, 1484~1493
- Lacorazza HD, "The emerging role of the myeloid Elf-1 like transcription factor in hematopoiesis", Blood Cells Mol Dis, 31, pp.342~350 (2003)
- Komori T, "Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts", Cell, 89, pp.755~764 (1997)
- Sato M, "Transcriptional regulation of osteopontin gene in vivo by PEBP2alphaA", CBFA1 and ETS1 in the skeletal tissues, 1998, pp.17, 1517~1525
- Wai PY, "Ets-1 and runx2 regulate transcription of a metastatic gene, osteopontin,in murine colorectal cancer cells", J Biol Chem, 281, pp.18973~18982 (2006)